Product Information

TRIAZOLAM 0.25 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3325 per EA under NDC 59762371803. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Nov 15, 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRIAZOLAM 0.25 MG TABLET

triazolam
$0.3325per EA
DEA Schedule CIV

Strength

.25 mg/1

NDC

59762371803

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TRIAZOLAM

Approval Type

Authorized Generic (NDA)

FDA Application

NDA017892

FDA Approved

11/15/1982

TE Code

AB

On Market Since

11/15/1982

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for TRIAZOLAM 0.25 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 48.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3325 per EA
All-time high$1.6632 (Mar 14, 2018)
All-time low$0.2380 (Nov 20, 2024)
52-week high$0.3691
52-week low$0.3011
Median price$1.0955
Average price$0.9840
Largest weekly change+51.7% (May 22, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+7.8%

3M

+4.6%

6M

-9.9%

1Y

-1.4%

3Y

-43.7%

5Y

-70.8%

All

-48.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRIAZOLAM 0.25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TRIAZOLAM 0.25 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.3325 per EA (NDC 59762371803), effective Nov 11, 2026.

How has the price of TRIAZOLAM 0.25 MG TABLET changed over time?

Over the history we have for it, the NADAC for TRIAZOLAM 0.25 MG TABLET has declined 48.1%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TRIAZOLAM 0.25 MG TABLET?

Since Nov 28, 2013, the NADAC for TRIAZOLAM 0.25 MG TABLET has ranged from a low of $0.2380 (Nov 20, 2024) to a high of $1.6632 (Mar 14, 2018), with a median of $1.0955 per EA.

Are there cheaper alternatives to TRIAZOLAM 0.25 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRIAZOLAM 0.25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TRIAZOLAM 0.25 MG TABLET?

TRIAZOLAM 0.25 MG TABLET (NDC 59762371803) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.